Trualt Bioenergy IPO Allotment Status: Check Overall Subscription & Steps to Verify Status

30 September 2025
3 min read
whatsapp
facebook
copyToClipboard

The subscription window for TruAlt Bioenergy IPO closed yesterday, on September 29, 2025. The allotment process for the IPO is expected to be finalised today, on September 30, 2025, and the company’s shares will be listed on both NSE and BSE.  The tentative listing date for Trualt Bioenergy's IPO is set for October 3, 2025.

Investors who applied for the IPO can now check the overall subscription details and allotment status here. Here’s a step-by-step procedure to check Trualt Bioenergy IPO Allotment Status on the NSE, BSE and registrar’s website.

Steps to Check TruAlt Bioenergy IPO Allotment Status on NSE

Here is the process to check TruAlt Bioenergy IPO Allotment on NSE:

  • Open the Application Status page of NSE here
  • Choose 'Equity & SME IPO bid details'. 
  • Select 'Trualt Bioenergy' from the list of companies. 
  • Enter your IPO application number and PAN details. 
  • Click the submit button to review the details of your share allotment. 

Steps to Check TruAlt Bioenergy IPO Allotment Status on BSE 

Here is the process to check the TruAlt Bioenergy IPO Allotment Status on BSE 

  • Open the Application Status page of BSE here
  • Choose 'equity' as the issue type. 
  • Select 'Trualt Bioenergy’ from the list of companies. 
  • Enter your IPO application number and PAN details. 
  • Verify the captcha by clicking on the 'I am not a Robot' box. 
  • Click the submit button to review the details of your share allotment.

Steps to Check TruAlt Bioenergy IPO Allotment Status on Bigshare Services Pvt Ltd (Registrar to the issue)

Here is the process to check TruAlt Bioenergy IPO Allotment Status on the registrar’s website:

  • Visit the Bigshare Services’ IPO allotment status page here
  • Click any of the server links. 
  • In Company Selection, select “Trualt Bioenergy”
  • Enter any of the following details: 
    • Application Number, 
    • Beneficiary ID or 
    • PAN. 
  • Enter the captcha and click “Search.”

TruAlt Bioenergy IPO Overall Subscription Status 

(September 29, 2025, end of the day)

Category 

Subscription (times)

Qualified Institutional Investors (QIBs)

165.15

Non-Institutional Investors

103.04

Individual Investors (IND category bidding for 2 Lots)

11.50

Total 

75.02

TruAlt Bioenergy - IPO Details

TruAlt Bioenergy IPO was a bookbuilding of ₹839.28 crores. The issue was a combination of a fresh issue of 1.51 crore shares, aggregating to ₹750.00 crores, and an offer for sale (OFS) of 0.18 crore shares, aggregating to ₹89.28 crores. The issue price band was set between ₹472 and ₹496 per share. The minimum lot size for an application was 30, and the minimum amount required for a retail investor was ₹14,160 (30 shares).

DAM Capital Advisors Limited and SBI Capital Markets Limited were the book-running lead managers, while Bigshare Services Private Limited served as the registrar for the IPO.

Check out newly Listed IPOs on BSE and NSE.

Utilisation of Proceeds

The Company will utilise the net proceeds from the issue for the following purposes:

  • Funding capital expenditure towards setting up multi-feed stock operations to pave the way for utilising grains as an additional raw material in ethanol plants at TBL Unit 4 of 300 KLPD capacity.
  • Funding the working capital requirements.
  • General corporate purposes.

Explore other Upcoming IPOs on BSE and NSE.

About TruAlt Bioenergy

TruAlt Bioenergy Ltd is one of India’s prominent biofuels/ethanol producers, headquartered in Bengaluru. It operates five distilleries in Karnataka with an installed ethanol production capacity of 2,000 kilolitres per day. The company is also active in compressed biogas (CBG) production through its subsidiary.

In FY25, TruAlt generated revenue of approximately ₹1,907.7 crore, a 56% increase from FY24, with profit after tax (PAT) rising to ₹146.6 crore from ₹31.8 crore in the same period.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory. 

To read the RA disclaimer, please click here.

Do you like this edition?